Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NuVasive Modulus-C Interbody System

K-Number: K223731 · 2023-01-12

Decision Date2023-01-12
Product CodeODP
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

NuVasive Modulus-C Interbody System is a medical device manufactured by Nuvasive, Inc.. It received FDA 510(k) clearance on 2023-01-12 under approval number K223731. The device is classified under product code ODP. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NuVasive Modulus-C Interbody System?

NuVasive Modulus-C Interbody System is a medical device that received FDA 510(k) clearance on 2023-01-12. It is manufactured by Nuvasive, Inc.. The 510(k) number is K223731.

When was NuVasive Modulus-C Interbody System approved by the FDA?

NuVasive Modulus-C Interbody System received FDA 510(k) clearance on 2023-01-12, under approval number K223731.

What company makes NuVasive Modulus-C Interbody System?

NuVasive Modulus-C Interbody System is manufactured by Nuvasive, Inc..

What is the FDA product code for NuVasive Modulus-C Interbody System?

The FDA product code for NuVasive Modulus-C Interbody System is ODP.

Related Clinical Trials

Other Devices by Nuvasive, Inc.

Related Devices (Code: ODP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.